Delivery Order SPE2DR25D1053-SPE2DR26FT643
Award Date 11/5/25
Potential Completion Date 11/6/25
Potential Value $26K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a Firm Fixed Price delivery order valued at $10,187.98 to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order valued at $4,702.10 to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamictal XR 300 mg tablets (30-count) valued at $9,889.10, with an ultimate completion date of August 7, 2025. This firm fixed-price, competitively awarded contract (no set-aside used) was executed on August 6, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a purchase of pharmaceutical inventory supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $7,691.99 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 50 mg tablets (30-count packages) under a firm fixed-price contract. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,389.64 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 300 mg tablets (30-count) under a firm fixed price contract type. The award, made on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $8,951.56 delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Lamictal XR 300 mg tablets, with an ultimate completion date of September 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $18,248.73 to supply Lamictal XR 50 mg tablets (30-count) with a firm fixed price structure and an ultimate completion date of March 26, 2025. This competitively awarded, non-set-aside contract was executed on March 25, 2025, with performance directed to the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) under a firm fixed-price contract valued at $5,644.62, with an ultimate completion date of April 28, 2025. This non-competitive, non-set-aside delivery order represents a standard pharmaceutical procurement transaction sourced from AmerisourceBergen's extensive federal contract portfolio. The place of performance is the vendor's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,783.85 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 250 mg tablets (30-count units). This firm fixed-price, competitively awarded contract was executed on October 24, 2025, with an ultimate completion date of October 27, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,154.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Lamictal XR 300 mg, a pharmaceutical product used to treat neurological conditions. This non-set-aside, competitively awarded contract was executed on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single...